Abstract
Subclinical hypothyroidism (SCH) is a biochemical diagnosis characterised by an elevated serum thyrotropin (TSH) concentration and a normal serum total or free thyroxine (FT4) level and occurs commonly in asymptomatic pregnant women with a frequency ranging from 2 to 20%. Its importance is that observational studies have linked SCH to a large variety of adverse outcomes in both mother and foetus, but intervention trials with Levo-thyroxine (LT4) replacement have shown no therapeutic benefit. Despite publication of several expert sets of management guidelines from relevant professional bodies over the past decade, consensus is lacking on specific laboratory diagnostic criteria, case-detection or universal screening and indications and outcomes from LT4 replacement therapy. In this review, we explore and compare the various serum TSH values and reference ranges recommended for diagnosis of gestational SCH; and the factors impacting these values and ranges, such as iodine deficiency and excess, underlying thyroid autoimmunity and the effect of the different analytical platforms used for measuring TSH levels. The application of American Endocrine Society guidelines results in possible overdiagnosis and overtreatment of SCH compared with the American Thyroid Association (ATA) guidelines where the reverse may apply in a small percentage of patients. We illustrate this finding with a comparative analysis of data on over 1000 women from our clinic screened for thyroid dysfunction during the first trimester of pregnancy. We conclude that systematic screening for hypothyroidism by TSH testing early in pregnancy may be worthwhile, being superior to recommended case-detection guidelines, and that low dose LT4 therapy should be introduced even when the degree of hypothyroidism is mild and does not cause immediate clinical manifestations in the woman. The evidence is that diagnosis and treatment should take place as soon as possible after pregnancy has been confirmed in the first trimester and should be monitored carefully throughout the pregnancy to prevent overtreatment.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Moleti M, Trimarchi F, Vermiglio F. Thyroid physiology in pregnancy. Endocr Pract. 2014;20:589–59.
DeGroot L, Abalovich M, Alexander EK, et al. Management of thyroid dysfunction during pregnancy and the postpartum: Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2012;97:2543–65.
Van den Boogard E, Vissenberg R, Land JA, Van Wely M, van der Post JAM, Goodijn M, Bisschop PH. Hum Reprod Update. 2011;17(5):605–19.
Maraka S, Ospina NM, O’Keeffe DT, et al. Subclinical hypothyroidism in pregnancy: a systematic review and meta-analysis. Thyroid. 2016;26:580–90.
Shinohara D, Rosani M, Santos T, de Carvalho HC, Lopes LC, et al. Pregnancy complications associated with maternal hypothyroidism: a systematic review. Obstet Gynaecol Surv. 2018;73:219–30.
Stagnaro-Green A, Abalovich M, Alexander E, Azizi F, Mestman J, Negro R, Nixon A, Pearce EN, Soldin OP, Sullivan S, Wiersinga W. American Thyroid Association taskforce on thyroid disease during pregnancy and postpartum 2011 guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid. 2011;21:1081–125.
Lazarus J, Brown RS, Daumerie C, Hubalewska-Dydejczyk A, Negro R, Vaidya B. 2014 European Thyroid Association guidelines for the management of subclinical hypothyroidism in pregnancy. Eur Thyroid J. 2014;3:76–94.
Alexander EK, Pearce EN, Brent GA, Brown RS, Chen H, Dosiou C, Grobman WA, Laurberg P, Lazarus JH, Mandel SJ, Peeters RP, Sullivan S. 2017 guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and the postpartum. Thyroid. 2017;27:315–89.
Korevaar TI, Medici M, de Rijke YB, Visser W, de Munck Keizer-Schrama SMPF, Jaddoe VWV, Hofman A, Ross HA, Visser E, Hooijkaas H, Steegers EAP, Tiemer H, Bongers-Schokking JJ, Visser TJ, Peeters RP. Ethnic differences in maternal thyroid parameters during pregnancy: the Generation R Study. J Clin Endocrinol Metab. 2013;98:3678–86.
da Silva VA, de Almeida RJ, Cavalcanta MP, Pereira LA Jr, Reis FM, Pereira MF, Kasamatsu TS, Camacho CP. Two thyroid stimulating hormone assays correlated in clinical practice show disagreement in subclinical hypothyroidism patients. Clin Biochem. 2018;53:13–8.
Andersen SL, Christensen PA, Knosgaard L, Andersen S, Handberg A, Hansen AB, Vestergaard P. Classification of thyroid dysfunction in pregnant women differs by analytical method and type of thyroid function test. J Clin Endocrinol Metab. 2020;105:e4012–22.
Yuen LY, Chan MHM, Sahota DS, Lit LCW, Ho CS, Ma RCW, Tam WH. Development of gestational age-specific thyroid function test reference intervals in four analytic platforms through multilevel modelling. Thyroid. 2020;30(4):598–608. https://doi.org/10.1089/thy.2019.0323.
Toloza F, Ospina NS, Rodriguez-Gutierrez R, O’Keeffe D, Brito J, Montori V, Maraka S. MON-586 practice variation in the management of subclinical hypothyroidism during pregnancy: results from a National Survey of Endocrinologists in the USA. J Endocrine Society. 2019;3(Suppl_1):MON-586.
American College of Obstetricians and Gynecologists. Thyroid disease in pregnancy: ACOG practice bulletin; number 223. Obstet Gynecol. 2020;135:e261–74.
Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG). Subclinical hypothyroidism and hypothyroidism in pregnancy; 2012: Subclinical-hypothyroidism-and-hypothyroidism-in-pregnancy-(C-Obs-46)-Mar18.pdf (ranzcog.edu.au).
Korevaar TIM, Derakshan A, Taylor PN, Meima M, Chen L, Bliddal S, McCarty D, et al. Association of thyroid function test abnormalities and thyroid autoimmunity with preterm birth: a systematic review and meta-analysis. JAMA. 2019;322:632–41.
Blumenthal N, Eastman CJ. Beneficial effects on pregnancy outcomes of thyroid hormone replacement therapy for subclinical hypothyroidism. J Thyroid Res. 2017;2017:4601365.
Eastman CJ, Ma G, Li M. Optimal assessment and quantification of iodine nutrition in pregnancy and lactation: laboratory and clinical methods, controversies, and future directions. Nutrients. 2019;11:2378. https://doi.org/10.3390/nu11102378.
Shi X, Han C, Li C, Mao J, Wang W, Xie X, et al. Optimal and safe upper limits of iodine intake for early pregnancy in iodine-sufficient regions: a cross-sectional study of 7190 pregnant women in China. J Clin Endocrinol Metab. 2015;100:1630–8.
Sang ZN, Wei W, Zhang GQ, Wen C, Hua L, Jun S, Liu JY, Zhang WQ. Thyroid dysfunction during late gestation is associated with excessive iodine intake in pregnant women. J Clin Endocrinol Metab. 2012;97:E1363–9.
Korevaar TIM, Steegers EAP, Pop VJ, Broeren MA, Chaker L, de Rijke YB, Jaddoe WV, Medici M, Vissre TJ, Tiemeier H, Peeters RP. Thyroid autoimmunity impairs the thyroidal response to hCG: two population based prospective cohort studies. J Clin Endocrinol Metab. 2017;102(1):69–77.
Pop VJ, Kuijpens JL, van Baar AL, Verkerk G, van Son MM, de Vijlder JJ, et al. Low maternal free thyroxine concentrations during early pregnancy are associated with impaired psychomotor development in infancy. Clin Endocrinol. 1999;50:149–55.
Maraka S, Mwangi R, et al. Variations in treatment practices for women with subclinical hypothyroidism in pregnancy: US national assessment. J Clin Endocrinol Metab. 2019;104:3893–901.
Maraka S, Singh Ospina NM, Mastorakos G, O’Keeffe DT. Subclinical hypothyroidism in women planning conception and during pregnancy: who should be treated and how? J Endocrine Soc. 2018;2:533–46.
Nazarpour S, Tehrani FR, Simbar M, Tohidi M, Minooee S, Rahmati M, Azizi F. Effect of levothyroxine on pregnant women with subclinical hypothyroidism negative for thyroid peroxidase antibodies. J Clin Endocrinol Metab. 2018;103:926–35.
Ge GM, Leung MTY, Man KKC, Leung WC, Ip P, Li GHI, Wong ICK, Kung AWC, Cheung CL. Maternal thyroid dysfunction during pregnancy and the risk of adverse outcome in the offspring: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2020;105:1–21.
Dhillon-Smith RK, Tobias A, Smith PP, Middleton LJ, Sunner KK, Baker K, Farrell-Carver S, Bender-Atik R, Agrawal R, Bhatia K, Chu JJ, Edi-Osgaie E, Ewles A, Ghobara T, Gupta P, Jukovic D, Khalaf Y, et al. The prevalence of thyroid dysfunction and autoimmunity in women with history of miscarriage or subfertility. J Clin Endocrinol Metab. 2020;105(8):dgaa302.
Lazarus JH, Bestwick JP, Channon S, Paradice R, Maina A, Rees R, Chiusano E, John R, Guaraldo V, George LM, et al. Antenatal thyroid screening and childhood cognitive function. N Engl J Med. 2012;366:493–501.
Casey BM, Thom EA, Peaceman AM, VarnerMW SY, Hirtz DG, Reddy UM, Wapner RJ, Thorp JM, Saade G, Tita ATN, Rouse DJ, Sibai B, Lams JD, Mercer BM, Tolosa J, Caritis SN, Van Dorsten JP. Treatment of subclinical hypothyroidism or hypothyroxinemia in pregnancy. N Engl J Med. 2017;376:815–24.
Man E, Jones WS. Thyroid function in human pregnancy: incidence of maternal low butanol extractable iodine and of normal TBG and TBPA capacities: retardation of 8-month-old infants. Am J Obstet Gynecol. 1969;104:898–908.
Haddow JE, Palomaki GE, Allan WC, Williams JR, Knight GJ, Gagnon J, O’Heir CE, Mitchell M, Hermos RJ, Waisbren SE, Faix JD, Klein RZ. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med. 1999;341:549–55.
Cooper DS, Pearce EN. Subclinical hypothyroidism and hypothyroxinemia in pregnancy—still no answers. N Eng J Med. 2017;376:876–7.
Negro R, Stagnaro GA. Diagnosis and management of subclinical hypothyroidism in pregnancy. BMJ. 2014;349:g4929.
Okosieme OE, Khan I, Taylor PN. Preconception management of thyroid dysfunction. Clin Endocrinol. 2018;89:269–79.
Negro R, Schwartz A, Gisomondi R, Tinelli A, Mangieri T, Stagnaro GA. Universal screening versus case finding for detection and treatment for thyroid dysfunction during pregnancy. J Clin Endocrinol Metab. 2010;95:1699–707.
Taylor PN, Zouras S, Min T, Nagarahaj K, Lazarus JH, Okosieme O. Thyroid screening in early pregnancy: pros and cons. Front Endocrinol (Lausanne). 2018;9:626. Published 2018 Oct 25. https://doi.org/10.3389/fendo.2018.00626.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Eastman, C.J., Blumenthal, N.J. (2022). Gestational Subclinical Hypothyroidism. In: Azizi, F., Ramezani Tehrani, F. (eds) Thyroid Diseases in Pregnancy. Springer, Cham. https://doi.org/10.1007/978-3-030-98777-0_7
Download citation
DOI: https://doi.org/10.1007/978-3-030-98777-0_7
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-98776-3
Online ISBN: 978-3-030-98777-0
eBook Packages: MedicineMedicine (R0)